|
Delayed
Japan Exchange
12:30:00 10/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,223.50 JPY | -0.60% |
|
-8.01% | +6.24% |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 01/09 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,011B 26.12B 22.47B 21.16B 19.28B 36.08B 2,485B 36.22B 251B 96.93B 1,266B 98.07B 95.94B | P/E 2027 * |
10.8x | P/E 2028 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3,952B 25.73B 22.14B 20.85B 19B 35.54B 2,449B 35.68B 247B 95.5B 1,247B 96.62B 94.52B | EV / Sales 2027 * |
1.7x | EV / Sales 2028 * | 1.64x |
| Free-Float |
98.88% | Yield 2027 * |
3.59% | Yield 2028 * | 3.72% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
OTC Markets
| ALPMF | Delayed | |
|
Boerse Muenchen
| YPH | Real-time | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Tradegate
| YPH | Real-time | |
|
Börse Stuttgart
| YPH | Delayed |
Last Transcript : Astellas Pharma Inc.
| 1 day | -0.60% | ||
| 1 week | -8.01% | ||
| Current month | -6.24% | ||
| 1 month | -5.90% | ||
| 3 months | +3.88% | ||
| 6 months | -8.02% | ||
| Current year | +6.24% |
| 1 week | 2,214.5 |  | 2,392 |
| 1 month | 2,214.5 | | 2,455 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 01/06/2019 |
| Director/Board Member | 59 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | -8.01% | +32.51% | +1.79% | 26.52B | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 649B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 440B | |
| -0.80% | -0.43% | +28.92% | +35.45% | 346B | |
| -0.13% | -14.97% | +9.41% | +26.71% | 263B | |
| -1.90% | -2.72% | -2.72% | +7.41% | 250B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 213B | |
| -1.06% | -4.23% | -14.70% | -57.36% | 201B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 182B | |
| Average | -0.57% | -4.53% | +23.89% | +38.29% | 357.02B | |
| Weighted average by Cap. | -0.42% | -3.89% | +31.99% | +56.60% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,329B 15.16B 13.05B 12.29B 11.2B 20.95B 1,443B 21.03B 146B 56.28B 735B 56.94B 55.71B | 2,155B 14.03B 12.08B 11.37B 10.36B 19.38B 1,335B 19.46B 135B 52.08B 680B 52.69B 51.55B |
| Net income | 356B 2.32B 1.99B 1.88B 1.71B 3.2B 220B 3.21B 22.25B 8.6B 112B 8.7B 8.51B | 333B 2.17B 1.86B 1.75B 1.6B 2.99B 206B 3B 20.79B 8.04B 105B 8.13B 7.95B |
| Net Debt | -59.18B -385M -332M -312M -284M -532M -36.67B -534M -3.7B -1.43B -18.68B -1.45B -1.42B | -481B -3.13B -2.69B -2.54B -2.31B -4.32B -298B -4.34B -30.05B -11.62B -152B -11.75B -11.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | JPY 2,223.50 | -0.60% | 1,537,200 |
| 09/09/26 | JPY 2,237.00 | -1.91% | 6,209,400 |
| 08/09/26 | JPY 2,280.50 | -0.98% | 3,779,100 |
| 07/09/26 | JPY 2,303.00 | -2.23% | 3,348,800 |
| 04/09/26 | JPY 2,355.50 | -2.54% | 5,484,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
